D-0296-2022 Class II Ongoing
FDA drug recall D-0296-2022 was initiated by Teligent Pharma, Inc. on Nov 30, 2021 and is designated Class II. Reason for recall: Superpotent Drug: Minimally superpotent The recall status is ongoing. Affected quantity: 7,176 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 5, 2022
- Initiation Date
- Nov 30, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,176 bottles
Product description
Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64
Reason for recall
Superpotent Drug: Minimally superpotent
Distribution pattern
Distributed to a wholesaler in CO who further distributed Nationwide in the USA
Code information
Lot #: 15594, Exp Date 05/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0296-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026